4372 related articles for article (PubMed ID: 6681340)
1. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
Kristensen E
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
[TBL] [Abstract][Full Text] [Related]
2. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of natural killer cells: correlation with emperipolesis and surface enzymes.
Burns ER; Zucker-Franklin D; Valentine F
Lab Invest; 1982 Jul; 47(1):99-107. PubMed ID: 7045522
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of natural cytotoxicity and the leukocyte migration inhibition in human melanoma stages I and II.
Kristensen E
J Cancer Res Clin Oncol; 1980; 96(2):181-91. PubMed ID: 7391115
[TBL] [Abstract][Full Text] [Related]
5. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
[TBL] [Abstract][Full Text] [Related]
6. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials.
Zaritskaya L; Shafer-Weaver KA; Gregory MK; Strobl SL; Baseler M; Malyguine A
J Immunother; 2009; 32(2):186-94. PubMed ID: 19238018
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I
Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
[TBL] [Abstract][Full Text] [Related]
8. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
9. Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
Molenkamp BG; Sluijter BJ; van Leeuwen PA; Santegoets SJ; Meijer S; Wijnands PG; Haanen JB; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2008 Jul; 14(14):4532-42. PubMed ID: 18628468
[TBL] [Abstract][Full Text] [Related]
10. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
[TBL] [Abstract][Full Text] [Related]
11. Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.
Ullberg M; Jondal M
Clin Exp Immunol; 1983 Jul; 53(1):101-8. PubMed ID: 6872324
[TBL] [Abstract][Full Text] [Related]
12. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
13. Natural killer activity of human lymphocytes against colon cancer cells.
Helms RA; Bull DM
Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
[TBL] [Abstract][Full Text] [Related]
14. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
[TBL] [Abstract][Full Text] [Related]
15. Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients.
Hersey P; Hobbs A; Edwards A; McCarthy WH; McGovern VJ
Cancer Res; 1982 Jan; 42(1):363-8. PubMed ID: 7053864
[TBL] [Abstract][Full Text] [Related]
16. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
17. Specific spontaneous cytotoxic activity in human T cell colonies.
Price GB; Teh HS; Miller RG
J Immunol; 1980 May; 124(5):2352-5. PubMed ID: 6767786
[TBL] [Abstract][Full Text] [Related]
18. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
19. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
Neville ME
J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
[TBL] [Abstract][Full Text] [Related]
20. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
